InMed Pharmaceuticals, Inc.

(CSE:IN) (OTC:IMLFF)

Company Description:

InMed Pharmaceuticals Inc. (CSE:IN) (OTC:IMLFF) is a biopharmaceutical company specializing in developing cannabis based therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. 

The company is utilizing its proprietary Intelligent Cannabinoid Drug Design Platform "IDP" to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific diseases.

Latest News & Stories on InMed Pharmaceuticals, Inc. (CSE:IN) (OTC:IMLFF)
Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.